Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Lisa Rydén"'
Autor:
Charlotte Jørgensen, Carina Forsare, Anna Karin Falck, Kristina Lövgren, Mårten Fernö, Pär-Ola Bendahl, Kristina Aaltonen, Lisa Rydén
Publikováno v:
Breast Cancer Research and Treatment
Purpose The study aimed to investigate expression of epithelial-to-mesenchymal transition (EMT)-related proteins and phenotypes during breast cancer progression and to relate this to patient outcome. Methods Protein expression patterns of E-cadherin,
Autor:
L. M. Fredrik Leeb-Lundberg, Christian Ingvar, Ulrik Narbe, Carina Forsare, Kristina Lövgren, Sara Alkner, Mårten Fernö, Lisa Rydén, Martin Sjöström, Pär-Ola Bendahl
Publikováno v:
Breast Cancer Research and Treatment
Purpose According to the 2017 St Gallen surrogate definitions of the intrinsic subtypes, Ki67, progesterone receptor (PR) and Nottingham histological grade (NHG) are used for prognostic classification of estrogen receptor (ER) positive/HER2-negative
Autor:
Maria Ekholm, Carina Forsare, Lisa Rydén, Pär-Ola Bendahl, Christine Lundgren, Bo Nordenskjöld, Olle Stål, Mårten Fernö, Ute Krüger
Publikováno v:
Breast Cancer Research : BCR
Breast Cancer Research, Vol 22, Iss 1, Pp 1-14 (2020)
Breast Cancer Research, Vol 22, Iss 1, Pp 1-14 (2020)
Background Tumour-infiltrating lymphocytes (TILs) are of important prognostic and predictive value in human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) and triple-negative breast cancer (TNBC), but their clinical relevance
Autor:
Carina Forsare, Pär-Ola Bendahl, Eric Moberg, Charlotte Levin Tykjær Jørgensen, Sara Jansson, Anna-Maria Larsson, Kristina Aaltonen, Lisa Rydén
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 8
International Journal of Molecular Sciences, Vol 21, Iss 2885, p 2885 (2020)
Volume 21
Issue 8
International Journal of Molecular Sciences, Vol 21, Iss 2885, p 2885 (2020)
Background: The estrogen receptor (ER) can change expression between primary tumor (PT) and distant metastasis (DM) in breast cancer. A tissue biopsy reflects a momentary state at one location, whereas circulating tumor cells (CTCs) reflect real-time
Autor:
Julia, Tutzauer, Martin, Sjöström, Pär-Ola, Bendahl, Lisa, Rydén, Mårten, Fernö, L M Fredrik, Leeb-Lundberg, Sara, Alkner
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231786 (2020)
PLoS ONE
PLoS ONE
Background G protein-coupled estrogen receptor (GPER), or G protein-coupled receptor 30 (GPR30), is reported to mediate non-genomic estrogen signaling. GPR30 associates with breast cancer (BC) outcome and may contribute to tamoxifen resistance. We in
Publikováno v:
APMIS. 126:746-754
Use of archived formalin-fixed paraffin-embedded (FFPE) tissue is a standard method for evaluation of proposed prognostic and predictive tumour markers. However, little is known of the preservation of biomarker expression in old FFPE tumour blocks. W
Autor:
Pär-Ola Bendahl, Kristina Aaltonen, Lisa Rydén, Anna Maria Larsson, Cecilia Graffman, Vendula Novosadova
Publikováno v:
Oncotarget
Resistance to systemic therapy is a major problem in metastatic breast cancer (MBC) that can be explained by initial tumor heterogeneity as well as by evolutionary changes during therapy and tumor progression. Circulating tumor cells (CTCs) detected
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Background Sentinel lymph node biopsy (SLNB) is standard staging procedure for nodal status in breast cancer, but lacks therapeutic benefit for patients with benign sentinel nodes. For patients with positive sentinel nodes, individualized surgical st
Autor:
Jari Häkkinen, Anna Ehinger, Tobias Sjöblom, Christine Lundgren, Marie Klintman, Cecilia Hegardt, Martin Malmberg, Lao H. Saal, Mårten Fernö, Helena Olofsson, Åke Borg, Niklas Loman, Pär-Ola Bendahl, Maria Ekholm, Christer Larsson, Johan Vallon-Christersson, Lisa Rydén, Henrik Lindman
Publikováno v:
Breast Cancer Research and Treatment
Purpose: Oestrogen receptor-positive (ER+) and human epidermal receptor 2-negative (HER2-) breast cancers are classified as Luminal A or B based on gene expression, but immunohistochemical markers are used for surrogate subtyping. The aims of this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bea33dbb0cefcb526c17a89e5b6bd81
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-396512
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-396512
Autor:
Cecilia Hegardt, Lao H. Saal, Henrik Lindman, Anna Ehinger, Niklas Loman, Lisa Rydén, Jari Häkkinen, Johan Staaf, Johan Vallon-Christersson, Tobias Sjöblom, Åke Borg, Martin Malmberg, Helena Olofsson, Fredrik Wärnberg, Christer Larsson
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-16 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-16 (2019)
Multigene expression signatures provide a molecular subdivision of early breast cancer associated with patient outcome. A gap remains in the validation of such signatures in clinical treatment groups of patients within population-based cohorts of uns
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::701bec1df2c5b7dfded55b4d9db66239
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-393727
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-393727